<?xml version="1.0" ?>
<tei type="book-chapter">
	<teiHeader>
		<fileDesc xml:id="55115341"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<reference>Chang, B.S. and Patro, S.Y. 2004. Freeze-drying Process Development for Protein<lb/> Pharmaceuticals. in &quot;Lyophilization of Biopharmaceuticals&quot; (Costantino, H.R. and Pikal,<lb/> M.J.eds) American Association of Pharmaceutical Scientists. Pp.113-138<lb/></reference>

	<docTitle>
	<titlePart>Freeze-drying Process Development for Protein Pharmaceuticals<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>BYEONG S. CHANG<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>Integrity Biosolution,</affiliation>
	</byline>

	<address>Newbury Park, CA<lb/></address>

	<byline>
	<docAuthor>SUGUNAKAR Y. PATRO<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>Amgen Inc.,</affiliation>
	</byline>

	<address>Thousand Oaks, CA<lb/></address>

	<div type="abstract">Abstract<lb/> This chapter provides an overview of the impact of protein formulation variables on<lb/> different stages of the protein freeze-drying process and offers guidance for selection of<lb/> critical process parameters during protein freeze-drying cycle development, optimization,<lb/> and scale-up. There is particular focus on practical considerations including large-scale<lb/> process development, scale-up challenges, and issues with less conventional freeze-<lb/>drying delivery systems, such as dual-chamber syringes.<lb/></div>

		</front>
	</text>
</tei>
